Javara has announced a strategic partnership with Nevada Health Centers (NVHC). Javara will employ and embed clinical research professionals within NVHC clinics to work alongside physicians and medical staff, providing aspects of operational collaboration to deliver clinical trials as a care option to their patients. The immediate focus of this new partnership is the NVHC Reno and Carson City locations. Javara and NVHC anticipate activation of the first clinical trials in internal medicine in the fall of 2023.
“As an FQHC (Federally Qualified Health Center), many patients served by Nevada Health Centers are from regions and demographic groups that have traditionally been sorely underrepresented in clinical trials,” said Jennifer Byrne, Javara founder and CEO. “Javara is grateful for the trust of Nevada Health Centers to bring access to novel treatments and innovative health care options to these communities for the first time. With a special focus on those patients with unmet medical needs in geographically isolated and otherwise marginalized regions, we are fully committed to the community benefit this partnership brings.”
“When seeking a partner to guide Nevada Health Centers’ efforts to develop a clinical trials program for our patients, Javara most closely aligned with our organizational mission and vision,” said Walter Davis, Nevada Health Centers' CEO. “We are a safety net provider for the community, and many of our patients live with chronic conditions. This partnership enables us to offer both access to innovative treatments and advanced education to our patients and establish a greater sense of trust in research. We are excited to be positioned as a contributor to the scientific knowledge base that helps improve the delivery and understanding of medicine.”
Javara, Nevada Health Centers Announce Partnership to Bring Clinical Research to the Geographically Isolated, Medically Underserved. (2023, August 7). Business Wire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.